Tissue kallikrein: A potential serum biomarker to predict delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage
- 1 March 2020
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 502, 148-152
Abstract
No abstract availableKeywords
Funding Information
- University of Chinese Academy of Sciences
This publication has 21 references indexed in Scilit:
- Tissue kallikrein protects SH‐SY5Y neuronal cells against oxygen and glucose deprivation‐induced injury through bradykinin B2 receptor‐dependent regulation of autophagy inductionJournal of Neurochemistry, 2016
- Precision medicine of aneurysmal subarachnoid hemorrhage, vasospasm and delayed cerebral ischemiaExpert Review of Neurotherapeutics, 2016
- The Pathophysiology of Delayed Cerebral IschemiaJournal Of Clinical Neurophysiology, 2016
- Human tissue kallikrein ameliorates cerebral vasospasm in a rabbit model of subarachnoid hemorrhageNeurological Research, 2015
- Aneurysmal Subarachnoid Hemorrhage: A Potentially Lethal Neurological DiseaseJournal of Emergency Nursing, 2015
- Diagnosis of cerebral vasospasm and risk of delayed cerebral ischemia related to aneurysmal subarachnoid haemorrhage: an overview of available toolsNeurosurgical Review, 2015
- Tissue kallikrein protects rat hippocampal CA1 neurons against cerebral ischemia/reperfusion‐induced injury through the B2R‐Raf‐MEK1/2‐ERK1/2 pathwayJournal of Neuroscience Research, 2014
- Impairment of Cerebral Autoregulation Predicts Delayed Cerebral Ischemia After Subarachnoid HemorrhageStroke, 2012
- Plasma tissue kallikrein level is negatively associated with incident and recurrent stroke: A multicenter case–control study in ChinaAnnals of Neurology, 2011
- Defining Vasospasm After Subarachnoid HemorrhageStroke, 2009